Search Results
Mar 23, 2026, 07:46 ET Bio-Thera Solutions Announces Further Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in India
changes in the company's financial conditions, and changes to applicable laws and regulations, etc. Forward-looking statements contained herein are made only as of the date of their initial publication. Unless required by laws or regulations, Bio-Thera Solutions undertakes no obligation to publicly update
More news about: Bio-Thera Solutions, Ltd
Mar 23, 2026, 07:45 ET Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers
forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.Investor Contact: Monique KosseGilmartin [email protected]
More news about: TuHURA Biosciences, Inc.
Mar 23, 2026, 07:00 ET Coveo Redefines Ecommerce Discovery with Search-Native Conversational AI
InformationThis press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws (collectively, "forward-looking information"). This forward-looking information is identified by the use of terms and phrases such as "may", "would",
More news about: Coveo Solutions Inc.
Mar 23, 2026, 07:00 ET Coveo Redefines Ecommerce Discovery with Search-Native Conversational AI
InformationThis press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws (collectively, "forward-looking information"). This forward-looking information is identified by the use of terms and phrases such as "may", "would",
More news about: Coveo Solutions Inc.
Mar 23, 2026, 07:00 ET BioLineRx Reports 2025 Financial Results and Provides Corporate Update
future revenues, capital requirements and its need for and ability to access sufficient additional financing; risks related to changes in healthcare laws, rules and regulations in the United States or elsewhere; competitive companies, technologies and BioLineRx's industry; BioLineRx's ability to maintain
More news about: BioLineRx Ltd.
Mar 23, 2026, 07:00 ET Insmed Announces Positive Topline Results from Phase 3b ENCORE Study of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with MAC Lung Disease
which the Company is dependent to manufacture sufficient quantities of ARIKAYCE for commercial needs, or to comply with the Company's agreements or laws and regulations that impact the Company's business; the Company's inability to create or maintain an effective direct sales and marketing infrastructure
More news about: Insmed Incorporated
Mar 23, 2026, 07:00 ET Quarterhill Reports Fourth Quarter and Full Year 2025 Financial Results
InformationThis news release contains forward-looking information and forward-looking statements within the meaning of applicable Canadian securities laws (collectively, "forward-looking statements") regarding Quarterhill, its operating subsidiaries and their respective businesses. Such forward-looking
More news about: Quarterhill Inc.
Mar 23, 2026, 06:59 ET Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)
of market acceptance, efficacy or safety; actions and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings on Viatris;
More news about: Viatris Inc.
Mar 23, 2026, 06:45 ET Jacobs completes acquisition of the remaining stake in PA Consulting
award of projects and funding and potential changes to governmental priorities and reduction in governmental spending, changes in U.S. or foreign tax laws, including the tax legislation enacted in the U.S. in July 2025, statutes, rules, regulations or ordinances, including the impact of, and changes to
More news about: Jacobs
Mar 23, 2026, 06:30 ET U.S. GoldMining Files PEA Technical Report for Its Whistler Project, Alaska
release constitutes "forward-looking statements" within the meaning of the United States federal securities laws and "forward-looking information" within the meaning of applicable Canadian securities laws (collectively, "forward-looking statements"). Such statements include statements with regard to the Company's
More news about: U.S. GoldMining Inc.
Mar 23, 2026, 06:30 ET Uranium Energy Corp Receives Approval for Expanded Production at Christensen Ranch and Secures NRC Docketing for U.S. Conversion Facility
27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and applicable Canadian securities laws. Where a forward-looking statement expresses or implies an expectation or belief as to future events or results, such expectation or belief is expressed
More news about: Uranium Energy Corp
Mar 23, 2026, 06:30 ET Nautical Ventures Adds AIATA Boat Brand to Its Product Portfolio
brand.Forward-Looking StatementsCertain statements in this press release constitute forward-looking statements within the meaning of applicable securities laws. These statements include, but are not limited to, statements regarding anticipated product introductions, brand expansion, market opportunities, and
More news about: Vision Marine Technologies, Inc
Mar 23, 2026, 06:00 ET Gamehaus Holdings Inc. Announces Unaudited Financial Results for the Second Quarter of Fiscal 2026 Ended December 31, 2025
the Securities Exchange Act of 1934, as amended, in accordance with applicable securities laws and other restrictions and subject to market conditions and in accordance with applicable federal securities laws. The timing and actual amount of repurchases will be determined at the discretion of the Company's
More news about: Gamehaus Holdings Inc.
Mar 23, 2026, 03:30 ET BellRing Brands, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - BRBR
BRBR) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information
More news about: DJS Law Group LLP
Mar 23, 2026, 03:24 ET ORCL Investors Have Opportunity to Join Oracle Corporation Fraud Investigation with the Schall Law Firm
filed with the SEC on March 15, 2024, and as supplemented on September 25, 2025 (together, the "Offering Documents"), for violations of the securities laws.
More news about: The Schall Law Firm
Mar 23, 2026, 02:12 ET NAVN Investors Have Opportunity to Lead Navan, Inc. Securities Fraud Lawsuit with the Schall Law Firm
NAVN) for violations of the federal securities laws.
More news about: The Schall Law Firm
Mar 23, 2026, 01:23 ET Navan, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NAVN
NAVN) for violations of the federal securities laws. Shareholders who purchased shares of NAVN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff
More news about: DJS Law Group LLP
Mar 22, 2026, 23:52 ET AIxCrypto Acknowledges Conclusion of SEC Investigation with no Enforcement Action Involving majority controlling stockholder, Faraday Future and Reaffirms Strategic Focus
and capital market conditions; the heavily regulated industry in which AIxCrypto carries on business; current or future laws or regulations and new interpretations of existing laws or regulations; the inherent volatility and regulatory uncertainty associated with cryptocurrency investments;
More news about: AIxCrypto Holdings Inc.
Mar 22, 2026, 20:52 ET ZYXIQ DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
www.faruqilaw.com.As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (a) Zynex shipped products, including electrodes, in excess of need; (b)
More news about: Faruqi & Faruqi, LLP
Mar 22, 2026, 18:13 ET NYSE: GDDY Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages GoDaddy Inc. (NYSE: GDDY) Investors to Contact the Firm
www.ktmc.com) a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by GoDaddy Inc. (GoDaddy) (
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 22, 2026, 17:11 ET NASDAQ: FRPT Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Freshpet, Inc. (NASDAQ: FRPT) Investors to Contact the Firm
www.ktmc.com) a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Freshpet, Inc. (Freshpet) (
More news about: Kessler Topaz Meltzer & Check, LLP
Mar 22, 2026, 10:40 ET Richtech Robotics (RR) Hit With Securities Class Action Amid Questions About Possible Pump and Dump - Hagens Berman
national shareholder rights law firm Hagens Berman to open an investigation into the complaint's claims that Richtech violated the federal securities laws. The firm urges Richtech investors who suffered significant losses to
More news about: Hagens Berman Sobol Shapiro LLP
Mar 22, 2026, 09:31 ET POM DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026
www.faruqilaw.com.As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that PomDoctor was the subject of a fraudulent stock promotion scheme
More news about: Faruqi & Faruqi, LLP
Mar 22, 2026, 09:28 ET RGNX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026
www.faruqilaw.com.As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: there was material adverse facts concerning the efficacy and safety of
More news about: Faruqi & Faruqi, LLP
Mar 22, 2026, 09:23 ET ALIT DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Alight (ALIT) Investors of Securities Class Action Deadline on May 15, 2026
www.faruqilaw.com.As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Alight's growth potential and financial stability; notably,
More news about: Faruqi & Faruqi, LLP